Riskpilot← Back to searchSign inGet full accessAPO INVEST AS
ASActiveOrg 982825989Bjørn Wirkolas Vei 15, 9510 AltaRetail sale of pharmaceutical products · NACE 4773Est. 20010 employees
Revenue 2024
NOK 0
EBITDA margin
—
-2% vs 2023
Equity ratio
5.4%
Financial strength
Net profit 2024
NOK 8,9M
+59% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -241K | -2% |
| Net profit | NOK 8,9M | +59% |
| Total assets | NOK 4,5M | -48% |
| Equity | NOK 247K | +3% |
| Employees | 0 | — |
Legal name
APO INVEST AS
Org number
982825989
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
12. januar 2001
Share capital
NOK 240 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Eie andre selskaper.
Address
Bjørn Wirkolas Vei 15, 9510 Alta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −63 | −120 | −181 | −236 | −241 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −63 | −120 | −181 | −236 | −241 |
| Net financials | 3 770 | 6 249 | 8 137 | 5 834 | 9 142 |
| Profit before tax | 3 707 | 6 130 | 7 955 | 5 598 | 8 901 |
| Tax | −10 | 20 | 4 | −0 | −0 |
| Net profit | 3 717 | 6 110 | 7 951 | 5 598 | 8 901 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 366 | 8 965 | 10 822 | 8 680 | 4 547 |
| Equity | 246 | 260 | 243 | 240 | 247 |
| Long-term debt | 2 600 | 2 600 | 2 600 | 2 800 | 300 |
| Short-term debt | 7 520 | 6 105 | 7 980 | 5 640 | 4 000 |
| Total debt | 10 120 | 8 705 | 10 580 | 8 440 | 4 300 |
EBITDA margin
-24087200.0%
This company
15.8%
Market median
-152450733% vs market
20202024
Equity ratio
5.4%
This company
38.2%
Market median
-86% vs market
20202024
Return on equity
3603.2%
This company
18.4%
Market median
+19483% vs market
20202024
Net profit margin
890111400.0%
This company
8.1%
Market median
+10989029530% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
17.41×
This company
0.62×
Market median
-2708% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HH Chief Executive Officer | Chief Executive Officer | 2003 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Chairman | 2011 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40% | 40% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dåvøy Invest As
APO INVEST AS Board members of APO INVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hege Hillestad | Chief Executive Officer | 0 companies |
| Anita Persen | Chairman | 0 companies |
| Steinar Johnsen | Board of Directors | 0 companies |
| Andreas Dåvøy | Board of Directors | 0 companies |
| Paul Tore Nielsen | Chairman | 0 companies |
| Inger Johanne Kristensen | Board of Directors | 0 companies |